期刊文献+

甲状腺癌的临床病理特征及预后分析 被引量:8

下载PDF
导出
摘要 目的深入研究甲状腺癌患者的临床病理特征以及预后影响的因素。方法选取我院在2017年4月至2018年1月接收的112例甲状腺癌患者作为研究对象,探究患者的临床特征以及手术治疗后的预后影响因素。结果超声诊断的检出率为68.33%,这120例甲状腺癌患者的主要病理类型为乳头状癌和滤泡状癌,分化型甲状腺癌。临床分期、多中心癌灶、患者年龄以及临床分期是对患者预后造成影响的四大独立因素。结论甲状腺癌的临床病例类型通常为分化型,对患者预后造成影响的因素多种多样,所以,应当根据患者的具体临床特征,采取差异化且有针对性的治疗方式。
作者 刘立波
出处 《中国医药指南》 2019年第4期138-139,共2页 Guide of China Medicine
  • 相关文献

参考文献3

二级参考文献34

  • 1施秉银.美国“甲状腺结节和分化性甲状腺癌诊断治疗指南”解读(Ⅰ)[J].中华内分泌代谢杂志,2006,22(2):194-194. 被引量:27
  • 2Sioka C. Female sex hormones and differentiated thyroid carcinoma [J]. Gynecological endocrinology, 2013, 29(2): 164.
  • 3Dalmo J, Rudqvist N, Spetz J, et al. Biodistribution of 177Lu-octreotate and lllln-minigastrin in female nude mice transplanted with human medullary thyroid carcinoma GOT2 [J]. Oncology reports, 2012, 27(1): 174-181.
  • 4Watanabe M, Fujioka K, Akiyama N, et al. Conjugation of Quantum Dots and JT95 IgM Monoclonal Antibody for Thyroid Carcinoma Without Abolishing the Specificity and Activity of the Antibody[J]. IEEE transactions on nanobioscience, 2011, 10(1): 30-35.
  • 5Kim E, Lim DJ, Lee K, et al. Absence of galectin-3 immunostaining in fine-needle aspiration cytology specimens from papillary thyroid carcinoma is associated with favorable pathological indices [J]. Thyroid, 2012, 22(12): 1244-1250.
  • 6Jung HK, Hong SW, Kim EK, et al. Diffuse sclerosing variant of papillary thyroid carcinoma: Sonography and specimen radiography [J]. Journal of Ultrasound in Medicine, 2013, 32(2): 347-354.
  • 7Watanabe M, Fujioka K, Akiyama N, et al. Conjugation of Quantum Dots and JT95 IgM Monoclonal Antibody for Thyroid Carcinoma Without Abolishing the Specificity and Activity of the Antibody[J]. IEEE transactions on nanobioscience, 2011, 10(1): 30-35.
  • 8Min J, Jeon J, Min H, et al. The prognostic value of the metastatic lymph node ratio and maximal metastatic tumor size in pathological Nla papillary thyroid carcinoma [J]. European journal of endocrinology, 2013, 168(2): 219-225.
  • 9Ahmadzadehfar H, Biermann K, Saber A, et al. A letter re garding diagnostic accuracy of ultrasound and 18-F-FDG PET or PET/CT for patients with suspected recurrent papillary thyroid carcinoma [J]. Ultrasound in Medicine and Biology, 2011, 37 (5): 840-840; author reply 841.
  • 10Taeymans O, Penninck D, Peters R, et al. Comparison between clinical, ultrasound, CT, MR1, and pathology findings in dogs presented for suspected thyroid carcinoma [J]. Veterinary Radiology & Ultrasound, 2013, 54(l): 61-70.

共引文献10

同被引文献62

引证文献8

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部